For research teamsHelp me find a study
Back to all studies
CompletedNCT00128479

Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant for depression

This study is completed in the United States. It is testing Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant for depression.

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether the Safety and Tolerability of Corlux may be useful for adults experiencing depression.

What would participation involve?

Participants may receive the Safety and Tolerability of Corlux, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateSeptember 2004
Recruitment status
Completed
Enrollment listed in the registry
443
Sponsor
Corcept Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00128479
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant vs. Placebo Plus an Antidepressant in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features (PMD)

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 44 sites
  • K&S Research Services
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Center for Emotional Fitness
    Cerritos, California
    Site status: Not listed — confirm with the team
  • Harbor Medical Associates, Inc.
    Fountain Valley, California
    Site status: Not listed — confirm with the team
  • Synergy Clinical Research Center
    National City, California
    Site status: Not listed — confirm with the team
  • Excell Research
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Pacific Clinical Research Medical Group
    Riverside, California
    Site status: Not listed — confirm with the team
  • AV Institute, Inc.
    Torrance, California
    Site status: Not listed — confirm with the team
  • Neuropsychiatric Institute of Orange County
    Westminster, California
    Site status: Not listed — confirm with the team
  • Geriatric and Adult Psych
    Hamden, Connecticut
    Site status: Not listed — confirm with the team
  • Comprehensive NeuroScience, Inc.
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Professional Clinical Research Inc.
    Fort Lauderdale, Florida
    Site status: Not listed — confirm with the team
  • Amit Vijapura, MD
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Tukoi Inst for Clinical Research
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Bioquan Research Group, Inc.
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • Scientific Clinical Research, Inc.
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • Mark Ashby, MD
    Sebring, Florida
    Site status: Not listed — confirm with the team
  • Stedman Clinical Trials, LLC
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Hawaii Clinical Research Center
    Honolulu, Hawaii
    Site status: Not listed — confirm with the team
  • Midwest Center for Neurobehavioral Medicine
    Oakbrook Terrace, Illinois
    Site status: Not listed — confirm with the team
  • Peryam and Kroll Health Care Research
    Schaumburg, Illinois
    Site status: Not listed — confirm with the team
  • Clintell, Inc.
    Skokie, Illinois
    Site status: Not listed — confirm with the team
  • CTT Research
    Prairie Village, Kansas
    Site status: Not listed — confirm with the team
  • Lake Charles Clinical Trials
    Lake Charles, Louisiana
    Site status: Not listed — confirm with the team
  • Louisiana Research Associates, Inc
    New Orleans, Louisiana
    Site status: Not listed — confirm with the team
  • LSU Health Sciences Center
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • Saaid Khojasteh & Assoc, Inc
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Medex Healthcare Research
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Albuquerque Neuroscience, Inc.
    Albuquerque, New Mexico
    Site status: Not listed — confirm with the team
  • Brooklyn Medical Institute
    Brooklyn, New York
    Site status: Not listed — confirm with the team
  • Advanced Bio-Behavioral Science, Inc
    Elmsford, New York
    Site status: Not listed — confirm with the team
  • Saint Vincent Catholic Medical Centers of New York
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Anxiety and Depression Clinic at Montefiore Medical Center
    The Bronx, New York
    Site status: Not listed — confirm with the team
  • Lutheran Hospital
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • Southwest Cleveland Sleep Center, Inc.
    Middleburg Heights, Ohio
    Site status: Not listed — confirm with the team
  • IPS Research Company
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Crossroads Counseling & Consulting Associates
    Moon Township, Pennsylvania
    Site status: Not listed — confirm with the team
  • CNS Research Institute (CRI)
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Segal Institute
    Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Harmony Research
    Johnson City, Tennessee
    Site status: Not listed — confirm with the team
  • UT Southwestern Medical Center
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • The Cedars Hospital, InSite Clinical Research
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Felin-Jennings Clinic
    Houston, Texas
    Site status: Not listed — confirm with the team
  • R&D Clinical Research, Inc.
    Lake Jackson, Texas
    Site status: Not listed — confirm with the team
  • America's Doctor/Essential Doctor, Inc
    Seattle, Washington
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00128479. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving mifepristone, mifepristone matched placebo, mifepristone 600 mg, mifepristone 1200 mg. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Corcept Therapeutics, which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.